Benzinga

Benzinga

Benzinga

sábado, septiembre 05

Privia Health Group Inc

PRVANASDAQ
Trade with Public
Trade with Public
$20.66
-0.01-0.05%
al cierre: Sep 4, 5:00 PM EST
$20.66
N/A
After hour: 4:00 PM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

Privia Health Gr Analyst Price Targets

Wall Street analyst price targets and consensus rating for Privia Health Gr (PRVA).

Price Target Range — 11 Quarters

Analyst Consensus — 20 Analysts

3S.Buy
16Buy
1Hold
Consensus RatingOutperform# Analysts20Avg. Consensus PT$29Upside to Avg. PT+39.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
May 26, 2026BarclaysAndrew MokPT CutEqual-Weight$25→$24
May 8, 2026Canaccord GenuityRichard ClosePT CutBuy$35→$34
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $34

Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $35 to $34.
Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on Privia Health Gr, Lowers Price Target to $26

Evercore ISI Group analyst Elizabeth Anderson maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and lowers the price target from $30 to $26.
Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Privia Health Gr, Raises Price Target to $25

Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and raises the price target from $23 to $25.
Benzinga Newsdesk

Breaking Down Privia Health Gr: 5 Analysts Share Their Views

Benzinga Insights

PRO
Citigroup Maintains Buy on Privia Health Gr, Lowers Price Target to $32

Citigroup analyst Daniel Grosslight maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $34 to $32.
Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Privia Health Gr, Raises Price Target to $33

Truist Securities analyst Jailendra Singh maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and raises the price target from $31 to $33.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved